" /> Nimotuzumab - CISMeF





Preferred Label : Nimotuzumab;

NCIt synonyms : TheraCim hR3; Thera-CIM-hr3;

NCIt related terms : Theraloc;

NCIt definition : A humanized monoclonal antibody directed against the epidermal growth factor receptor (EGFR) with potential antineoplastic activity. Nimotuzumab binds to and inhibits EGFR, resulting in growth inhibition of tumor cells that overexpress EGFR. This agent may act synergistically with radiation therapy.;

Alternative definition : NCI-GLOSS: A monoclonal antibody being studied in the treatment of some types of cancer. Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. Nimotuzumab binds the epidermal growth factor receptor (EGFR) and blocks cancer cells that depend on epidermal growth factor for growth.;

UNII : 6NS400BXKH;

CAS number : 828933-51-3; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 828933-51-3 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Drug name : Theraloc;

Molecule name : H-R3;

Codes from synonyms : CDR0000538634; CDR0000572210;

Details


You can consult :


Nous contacter.
12/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.